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Background: An increasing proportion of malaria cases diagnosed in UK residents with a history of travel to
malaria endemic areas are due to Plasmodium falciparum.
Methods: In order to identify travellers at most risk of acquiring malaria a proportional hazards model was used to
estimate the risk of acquiring malaria stratified by purpose of travel and age whilst adjusting for entomological
inoculation rate (EIR) and duration of stay in endemic countries.
Results: Travellers visiting friends and relatives and business travellers were found to have significantly higher
hazard of acquiring malaria (adjusted hazard ratio (HR) relative to that of holiday makers 7.4, 95% CI 6.4–8.5,
p < 0. 0001 and HR 3.4, 95% CI 2.9-3.8, p < 0. 0001, respectively). All age-groups were at lower risk than children
aged 0–15 years.
Conclusions: These estimates of the increased risk for business travellers and those visiting friends and relatives
should be used to inform programmes to improve awareness of the risks of malaria when travelling.
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The majority of travellers to malaria endemic areas
(~6.5million per year from the UK [1]) do not contract
malaria due to the uptake of preventative and personal
protective measures such as malaria chemoprophylaxis,
bed nets and insect repellent. Nevertheless, malaria
acquired in endemic regions and imported into non-
endemic countries accounts for a considerable and largely
preventable burden of morbidity and mortality throughout
Europe [2,3]. The UK has one of the highest rates of
imported malaria among non-endemic countries, with
around 2,000 cases per year resulting in five to 16 deaths
[4]. Whilst there has been a decrease in imported malaria
cases in the UK since 2000, the UK saw an increase in the
number of cases imported in 2010 and 2011 [5]. Over this
period there has also been an increase in the proportion
of cases attributable to Plasmodium falciparum rather
than Plasmodium vivax [3]. Plasmodium falciparum is
associated with severe symptoms and mortality [6-8]. It is,* Correspondence: deirdre.hollingsworth@warwick.ac.uk
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unless otherwise stated.therefore, important to identify groups at high risk of
contracting malaria to effectively target preventative
health advice. Developing reliable measures of risk in the
wider travelling population is also necessary to inform
proposals to reduce levels of chemoprophylaxis amongst
those travelling to low risk areas [9,10]. The work
presented here focuses on P. falciparum in 2007, not only
because of to its serious consequences, but because of the
availability of detailed global estimates of P. falciparum
parasite prevalence in 2007 [11,12] and a model
which can be used to convert these estimates to the
entomological inoculation rate (EIR) [13].
A large proportion of UK malaria cases are acquired
whilst travelling to visit friends and relatives (hereafter
referred to as VFR) [14,15]. The majority of these infections
are acquired in West Africa [16], even though these areas
are not frequent destinations for UK residents [3,14].
Travellers VFR visit areas where malaria is more readily
transmitted and tend to stay for longer than those who
travel for any other purpose [17-20]. An increase in risk of
infection beyond that due to increased exposure and
longer duration of travel is supported by the observation
that travellers VFR have often lived in malarial areas previ-
ously and may assume that they are immune, even thoughLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vent infection [18-23]. Studies have also suggested that indi-
vidual concerns about health care services and side-effects
of chemoprophylaxis present themselves as barriers to
uptake of chemoprophylaxis in VFR travellers [24]. This
perception of immunity and distrust of health services
may help to explain poor uptake of prophylaxis and
pre-travel health advice amongst travellers VFR [3,25]
as well as the large number of cases in this group.
A number of imported cases are in children (10% under
the age of 15 in 2007), suggesting that they may be at
higher risk of acquiring malaria as travellers [7]. Children
are believed to be at greater risk of acquiring malaria in
general and children <6 years of age have a significantly
higher risk of presenting with clinical malaria [7,26]. In
addition, adequate uptake of, and compliance with,
prophylaxis by children may be poor, particularly when
travelling with family members for the purposes of visiting
friends and relatives [21,22,26-28]
The risk of acquiring malaria whilst visiting a malaria
endemic country is multi-factorial. Longer duration of
stay and higher transmission rates in the destination
country increase the probability of acquisition, as does
poor adherence to preventative measures. Most previous
analyses have highlighted this, but the majority have
been unable to disentangle these different effects. A more
recent study characterized transmission risk in the destin-
ation country by malaria incidence and found that
this did not correlate well with the risk of travellers
acquiring malaria [9]. When this model was extended to
account for duration of stay in high risk areas, it was
shown that chemoprophylaxis of travellers may only be
cost effective in moderate to high incidence areas [29]. In
this study a more direct measure of exposure, the entomo-
logical inoculation rate (EIR), or the number of infectious
bites per person per year, calculated from parasite
prevalence estimates for 2007 [11,12], is used to estimate
the risk of acquiring malaria in different groups of
travellers.
Methods
Data sources
UK cases of Plasmodium falciparum in 2007
The Malaria Reference Laboratory (MRL) of the UK
Health Protection Agency (HPA) obtained detailed pas-
sive surveillance reports on cases of malaria (confirmed by
blood films or tissue histology) from clinicians and labora-
tories in the UK [3]. The notifying laboratory and clinician
provided data on exposure risk for each case, including
their country of usual residence (excluding non-UK resi-
dents), the reason for travel, the country or region visited
and duration of travel. Whilst there is likely to be underre-
porting of cases of malaria in the UK, these data give the
most comprehensive picture of imported malaria in the UK.UK travellers to malaria endemic areas
The travel patterns of UK residents were obtained
from two sources. Firstly, the number of visitors to each
country was collated from World Tourism Organization
(WTO) data from member states on the number of visitors
to each country by country of residence [1]. Data
from 2007 was used if available, or for the closest
year for which data were available, and online sources
of information for the few countries for which no
data were available.
Secondly, data on the purpose of travel and the age of
travellers to malaria endemic areas were obtained
from the TravelPac, provided by the Office for National
Statistics [30]. These data are collected as part of the
International Passenger Survey (IPS) in which personal
interviews are conducted with approximately 250,000
randomly selected travellers annually (~0.2% of the total).
The data are stratified by country unless the sample size is
too small in which case data are aggregated across
countries. Since only a small proportion of UK travellers
visit malaria endemic areas, the data in this survey on the
proportion of travellers visiting for particular reasons or
within particular age-groups has to be aggregated across
several malaria endemic countries. For example, since
“Other Africa” included 43 African countries, the
proportion of the UK visitors aged 0–15 years of age
who visited friends and relatives was the same across
a number of African countries. To overcome this
limitation in the data, searches for other data sources
were carried out, but extensive internet searches only
found data on reason for travel from an extremely
limited number of countries and the data was never
stratified for travellers from the UK (Additional file 1).
Therefore this analysis uses the systematic data collected
by the IPS, despite its clear limitations, since it is the
only source for data systematically captured from UK
travellers. To investigate the impact of this assumption
the analysis was repeated for just Uganda, which had the
most suitable travel data.
Within-country transmission rate
Malaria transmission is highly heterogeneous at all scales,
from continent to village [12,31,32]. Since the destination
of travel for malaria cases is only reported at the country
level, the exposure risk (EIR) was estimated as an average at
the country level. P. falciparum parasite prevalence esti-
mates in 2–10 year olds were transformed to population-
weighted national-level mean EIR estimates by first using
the relationship derived from fitting of a mathematical
model to data on the EIR to prevalence amongst 2–10 year
olds relationship from 34 locations across Africa [13]
and then calculating the population-weighted mean
(see Additional file 2 and [11,12]). In order to investigate
sensitivity to this assumption of population weighting
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within a country.
Statistical analysis
Crude incidence
To demonstrate general trends in the data the incidence
of imported malaria to the UK in 2007 was calculated
for three key variables of interest: reason for travel, age
group and EIR (depending on destination visited).
Incidence was calculated as number of cases imported
by each group of interest divided by the total number of
visitors to all malaria endemic areas (MEAs) in that
group as provided in the WTO data for country and IPS
data for reason for travel and age. Binomial confidence
intervals were calculated. This analysis does not account
for missing data, and therefore a more sophisticated
model was used for the full analysis.
Statistical model
In order to assess the relative hazards faced by different
travellers, it was assumed that the risk of acquiring
malaria depends on the daily level of exposure (the EIR)
and the duration of stay in a malarial endemic country.
As such, it was assumed that the probability of infection
per bite is the same for all individuals in all transmission
settings. A log-linear model was used to calculate the
hazard of acquiring malaria in which the time of
infection was assumed to have occurred at any point
during the reported visit to a malaria endemic area and
the daily hazard of infection is determined by the EIR
(assuming a constant rate and thus ignoring both any
nonlinear relationship between EIR and force of infection
and any seasonality in transmission since data on the
months of visits was not available). Two covariates
were considered both in univariable and multivariable
models – the age of the participant (as a categorical
variable) and the reported reason for travel (a detailed
description of the model and model equations are
provided in Additional file 3). The hazard was calculated
as an aggregate measure of the effect of the use of
preventative measures, such as bed nets, insect repellent
and chemoprophylaxis, because detailed usage statistics
were not available for travellers in general.
Since one or more of the covariates or the destination of
travel were missing for a proportion of cases (235 (23%)
missing information on destination, 455 (45%) missing
reason for travel and 4 (<1%) missing age), parameter esti-
mation was performed using an expectation-maximization
algorithm [33]. A detailed description of the method is
provided in Additional file 3.
Results
One thousand, one hundred and fifty four cases of P.
falciparum were reported by the malaria referencelaboratory in 2007. Excluding those who were not UK
residents, whose country of residence was unknown and
those whose purpose of travel were foreign visitor, a
new entrant to the UK or foreign students, resulted
in 1004 cases. Of these, 11 were mixed infections: three P.
falciparum/P. vivax, four P. falciparum/Plasmodium
malariae and four P. falciparum/Plasmodium ovale. In
those cases for whom the country of travel was reported
(796/1004, 79%), the most frequent country where the
cases had contracted malaria were Nigeria (365 cases,
46%), Ghana (147 cases, 18%) and Uganda (54 cases, 7%)
(Figure 1A). Travellers from the UK visit a number of
malaria endemic countries (Figure 1B), and their
destinations reflect a large range of EIR (Figure 1C).
For those malaria cases that reported their reason for
travel (573/1,004, 57%), the most common reason was
travelling to visit friends and relatives (VFR), Table 1.
Most cases were reported amongst adults aged 24 to
55 years of age, although there were a substantial
number of children (Table 1).
Across all traveller groups to MEAs VFR travellers had
the highest crude incidence of malaria cases at 2.3 cases
per 10,000 travellers (95% CI 2.1-2.5) (Figure 2, Table 1).
Business travellers also had a high level of crude incidence,
with 0.45 cases per 10,000 travellers (95% CI 0.31-0.61).
When considering age alone, children aged 0–15 years
had the highest incidence (3.2, 95% CI (2.6-3.9), while
adults aged 55–64 years had the lowest incidence of
all age groups (0.95 cases per 10,000 travellers (95%
CI 0.70-1.23)). There was increasing incidence with
increasing EIR (Figure 2C).
Using the full statistical model which accounted
for missing data, the univariable analyses showed
that including purpose of travel and age significantly
improved the fit of the model (p < 0.0001, Table 2).
The parameter estimates were similar for both the
univariable and multivariable models (including both
reason for travel (p < 0.0001) and age (p < 0.0001)),
as such, the results from the multivariable model are
focused on. Both travellers visiting friends and relatives
(adjusted HR 7.4, 95% confidence interval (CI) 6.4-
8.5, p < 0.0001) and business travellers (adjusted HR
3.4, 95% CI 2.9-3.8, p < 0.0001) were at significantly
higher risk compared to holiday-makers (Table 2).
When the univariable analysis was repeated without
missing data, using the 438 of 1,004 cases in the
database the hazard ratios had a similar qualitative
pattern, but with lower magnitude of the increased risk
for travellers visiting friends and relatives (adjusted
HR 2.5 (2.3-2.7), p < 0.0001) and business travellers
(adjusted HR 1.6 (1.4-1.7), p < 0. 0001). Those travelling
for miscellaneous reasons remained at lower risk
(adjusted HR 0.87 (0.80–0.94), p = 0.03) compared to
holiday-makers.
Figure 1 Maps of the country of origin of P. falciparum cases amongst UK residents travelling to malaria endemic areas in 2007,
number of UK residents travelling to each malaria-endemic country and the estimated entomological infection rate for each malaria-endemic
country. (A) The number of cases imported to the UK in 2007 by country of reported travel exposure. (B) The number of UK residents travelling
to malaria-endemic areas in 2007 [1]. White areas are those that are considered non-endemic. (C) Estimated entomological infection rate
(EIR, in units of infectious bites per person per year) for each malaria-endemic country.
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model (likelihood ratio test p < 0.0001, Table 2). All age
groups were at lower risk than children (0–15 years old)
(Table 2).
When the analysis was repeated using EIR weighted by
area, rather that population, the same qualitative patterns
were found, with small changes in the quantitative values
of the relative hazards (Additional file 4). For example, in
the multivariable model the adjusted hazard ratio for
travellers visiting friends and relatives was 8.2 (6.4-10.8),
and for business travellers it was 3.6 (2.7-4.9). The analysiswas also repeated for solely Uganda with different
assumptions on travel patterns, where the qualitative
patterns were also similar to those across the whole
dataset (Additional file 5).
Conclusions
In 2007, 1,004 cases of P. falciparum malaria were
reported from amongst approximately 6.5 million UK
residents travelling to malaria endemic areas. By
comparing the characteristics of these cases with those of
all UK travellers to these areas, and adjusting for the
Table 1 Characteristics of cases of imported malaria in the UK in 2007 and crude incidence for each group
Cases (%) Travellers 1,000 s (%) [30] Duration of visit (days) Median (IQR*) Crude incidence per 10,000
Purpose
VFR 450 (82%) 1,976 (30%) 23 (14–40) 2. 3 (2. 1–2. 5)
Misc* 6 (1. 3%) 282 (4%) 300 (14–365) 0. 21 (0. 1–0. 4)
Business 35 (6. 4%) 774 (12%) 30 (16–89) 0. 45 (0. 31–0. 61)
Holiday 58 (11%) 3,638 (55%) 19 (14–42) 0. 15 (0. 12–0. 20)
Missing 455 30 (19–42)
Age group (years)
0–15 97 (9. 7%) 302 (4. 5%) 30 (21–85) 3. 2 (2. 6–3. 9)
16–24 102 (10%) 611 (9%) 30 (17. 5–51) 1. 7 (1. 4–2. 0)
25–34 198 (20%) 1,520 (23%) 25 (14–42) 1. 3 (1. 1–1. 5)
35–44 270 (27%) 1,424 (21%) 21 (14–32) 1. 9 (1. 7–2. 1)
45–54 203 (20%) 1,345 (20%) 21 (14–30) 1. 5 (1. 3–1. 7)
55–64 83 (8. 3%) 973 (14. 5%) 30 (15–55. 5) 0. 85 (0. 68 – 1. 04)
65+ 47 (4. 7%) 495 (8%) 58. 5 (30–116) 0. 95 (0. 70–1. 23)
Missing 4
Total 1,004 6,670
*Misc: Miscellaneous purpose of travel. IQR: Inter-quartile range.
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estimates suggest that travellers VFR and, independently,
young children are at significantly higher risk of acquiring
malaria than other groups. These risks are an aggregate
measure of many factors, including chemoprophylaxis,
bed net usage and other preventative measures.Figure 2 Crude incidence per 10,000 travellers stratified by (A) reasonTravellers VFR have been identified as a high risk
group due to the large number of cases in this group, but
previous estimates of enhanced risk have not allowed for
an increased EIR in the place that is visited nor their long
duration of stay in these areas [3,18,34,35]. The increased
risk of acquiring malaria for travellers VFR is likely to be afor travel, (B) age group and (C) EIR in country of travel.
Table 2 Estimated hazard ratio (univariable model) and adjusted hazard ratio (multivariable model) for acquiring
malaria conditional on the estimated level of exposure in the destination country
Hazard Ratio (95% confidence interval) p Adjusted hazard ratio (95% confidence interval) p
Purpose <0. 0001* <0. 0001*
VFR 6. 3 (5. 6–7. 0) <0. 0001 7. 4 (6. 4–8. 5) <0. 0001
Misc* 0. 43 (0. 29–0. 58) <0. 0001 0. 43 (0. 27–0. 59) <0. 0001
Business 2. 4 (2. 0–2. 9) <0. 0001 3. 4 (2. 9–3. 8) <0. 0001
Holiday 1 1
Missing
Age group (years) <0. 0001* <0. 0001*
0–15 1 1
16–24 0. 41 (0. 31–0. 58) 0. 002 0. 58 (0. 43–0. 80) <0. 0001
25–34 0. 20 (0. 16–0. 26) <0. 0001 0. 26 (0. 19–0. 32) <0. 0001
35–44 0. 22 (0. 18–0. 31) <0. 0001 0. 22 (0. 17–0. 28) <0. 0001
45–54 0. 31 (0. 24–0. 41) <0. 0001 0. 44 (0. 33–0. 55) <0. 0001
55–64 0. 36 (0. 26–0. 49) <0. 0001 0. 55 (0. 41–0. 77) <0. 0001
65+ 0. 49 (0. 33–0. 76) <0. 0001 0. 45 (0. 31–0. 65) <0. 0001
Missing
Total
*Significance test for inclusion of the covariate obtained using likelihood ratio tests. IQR: Inter-quartile range. Misc: Miscellaneous purpose of travel.
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chemoprophylaxis and the perception that areas they
stay in are likely to be low risk. Some of these travellers
assume that they are immune to malaria due to previous
exposure and as a result are less likely to seek pre-travel
advice or protect themselves from infection [18,24,36].
Whilst this may indeed be the case for some (perhaps
explaining the reduced hazard of acquisition in adults),
others may be susceptible. Moreover, recent work
highlighted that VFR travellers felt that even if they
became infected while staying with friends or relatives, the
disease could be dealt with relative ease [37]. This may
imply that VFR travellers are less likely to perceive malaria
as high risk infection. These results suggest that this group
continues to be an important target for prevention messages.
Business travellers also appear to be at increased risk
of acquiring infection compared to holiday-makers in
both models assessed in this work. Whilst this risk group
has not previously been identified in the UK, data from
Scotland in 2006–2008 showed that business travellers
imported a greater number of cases than VFR travellers
despite high reported prophylaxis uptake [16]. Business
travellers have also been identified as a risk group in Japan
and Switzerland [38,39], and they are a large and increasing
group of patients in Europe (almost 19% [1,40,41]), and in
the UK the number of business traveller cases has almost
doubled between the period 2007–2011 [5]. Even after
accounting for duration of stay business travellers
were at an increased risk of infection acquisition, this may
be because some business travellers avoid protectivemeasures because they travel for short periods or stay in
more industrial areas [42] and they are less likely to seek
medical advice than tourists [39]. Thus their lack of
knowledge, poor awareness and resulting behavior
could all contribute to their higher risk.
Imported malaria in children is a complex problem
that faces many challenges [43]. The results suggest that
children aged 0–15 years could be at a higher risk of
infection than other age groups. This is consistent
several previous studies [26,44,45]. However, a number
of other studies have identified a different pattern of
results, which may suggest that young children could be
at a reduced risk of acquiring infection relative to other
age groups [28,46]. These studies have often focused on
children less than five years of age, while this work has
assessed a wider age range. Cases in children are of
particular concern because of the increased potential for
both rapid onset of severe disease, non-specific symptoms
and delayed diagnosis in this group [7,28,47,48]. Children
of a young age may be at increased risk due to intrinsically
higher susceptibility. The use of prophylaxis or personal
protective measures remains largely inadequate within this
age group, especially amongst those travelling to VFR
[28,43]. This altered risk is reflected in case numbers, and
should be a priority for public health interventions.
There are a number of limitations of this study. First,
it is based on passive surveillance of malaria cases,
which is believed to be subject to large underreporting.
Second, for some aspects, particularly the reason for
travel, there was a large proportion of missing data.
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mechanism underlying the algorithm used assumes that
the data are missing at random. In practice, this may not
hold if the reason for travel is systematically not
reported by certain groups. Improved recording of this
information would be of benefit in defining the groups
at highest risk. Equally, data on reason for travel was
assumed to be the same across 43 African countries,
however there is heterogeneity in reasons for travel to
different regions of Africa. Given the limited data
available at the country level on purpose of travel it was
chosen to keep the proportions available in the TravelPac
data. Malaria risk varies substantially within countries.
Robert et al. [49] identified a loose linear relationship
between mean annual EIR and degree of urbanization.
Coupled with this it is also likely that different traveller
groups will visit places with variable levels of urbanization,
this will affect the force of infection that travellers are
exposed to [50]; however the travel destination of cases
was only recorded at country level. It was assumed that
the distribution of risk which was aggregated according to
the population density within each country [11] was the
same as the distribution of risk for travellers, which is
unlikely to be true for some travel groups. More specific
recording of the destination of UK cases at sub-national
level would improve estimates of risk [11]. Travel patterns
can differ between different reason for travel groups [51],
this may result in different forces of infection being
experienced by different travel groups at different
times of the year as a consequence of different travel
preferences at different times of the year, this could
result in the seasonal reporting of cases.
Current public health strategies are effectively protecting
the majority of UK travellers to malaria endemic areas.
However, there are still a number of cases reported each
year. This analysis supports previous calls to improve health
education and access to prophylactic drugs in immigrant
communities in the UK, particularly children. The other
group identified here are business travellers, whose percep-
tion of the risk of acquiring malaria may be poor, particu-
larly when they are staying for longer than is usual for
business travellers. Efforts should, therefore, be made to
ensure that prevention messages are reaching this group.Additional files
Additional file 1: Purpose of Travel data. Country level data for
purpose of travel to different malarial endemic areas.
Additional file 2: The relationship between PfPR2-10 and EIR. The
relationship between PfPR2-10 is illustrated and the details and appropriate
citations are provided for the PfPR data, and how it was converted to EIR.
Additional file 3: Statistical methods. A description of the
proportional hazards model developed and an explanation of the
expectation maximization algorithm applied to the missing data.Additional file 4: A sensitivity analysis to the assumptions about
EIR within country. Estimated hazard ratios for the univariable and
multivariable models, where the parasite rate across the country was
unweighted by population and then converted to EIR.
Additional file 5: Sensitivity to uncertainty in travel patterns – analysis
of Uganda. A sensitivity analysis on uncertainity in travel patterns
using Uganda case data. Univariable and multivariable model are
presented for estimated hazards using data from the IPS survey and
international traveller data.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TDH, JMR conceived the study, TDH, JMR and JTG designed the analysis. AP
and TDH analysed the data. PWG and VS collected and contributed data. All
authors wrote and contributed to the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
The authors gratefully acknowledge funding from Imperial College (TDH
Junior Research Fellowship), Bill & Melinda Gates Vaccine Modeling Initiative
(TDH, JG, ACG), the Medical Research Council (UK) for project funding (JMR)
and Centre funding (ACG) and the Economic and Social Research Council
(UK, JMR, grant ES/K004255/1). PWG is a Medical Research Council (UK)
Career Development Fellow (#K00669X) and receives support from the Bill
and Melinda Gates Foundation (#OPP1068048). TDH is a member of the
Centre for Applied Health Research & Delivery (http://www.lstmliverpool.ac.
uk/research/cross-cutting-themes/cahrd/) which is supported by a Wellcome
Trust Institutional Strategic Support Award (no. 097830/Z/11/A-C) to LSTM.
Author details
1Department of Infectious Disease Epidemiology, MRC Centre for Outbreak
Analysis and Modelling, School of Public Health, Faculty of Medicine, Imperial
College London, St Mary’s Campus, Norfolk Place, London W2 1PG, UK.
2Department of Epidemiology and Population Health, Faculty of Health and
Life Sciences, Institute of Infection and Global Health, University of Liverpool,
Liverpool, UK. 3NIHR Health Protection Research Unit in Emerging and
Zoonotic Infections, Liverpool L69 7BE, UK. 4Public Health England, Malaria
Reference Laboratory, London School of Hygiene & Tropical Medicine,
Keppel St, London WC1E 7HT, UK. 5Department of Zoology, Spatial Ecology
and Epidemiology Group, Tinbergen Building, University of Oxford, South
Parks Road, Oxford, UK. 6Department of Infection & Tropical Medicine,
Imperial College London, Lister Unit, Northwick Park Hospital, Middlesex HA1
3UJ, UK. 7Warwick Mathematics Institute, University of Warwick, Coventry CV4
7AL, UK. 8School of Life Sciences, University of Warwick, Coventry CV4 7AL,
UK. 9Department of Clinical Sciences, Liverpool School of Tropical Medicine,
Pembroke Place, Liverpool L3 5QA, UK.
Received: 10 December 2013 Accepted: 27 July 2014
Published: 4 August 2014
References
1. Tourism Factbook. http://www.wtoelibrary.org/content/v486k6/?v=search.
2. Driessen GJ, Pereira RR, Brabin BJ, Hartwig NG: Imported malaria in
children: a national surveillance in the Netherlands and a review of
European studies. Eur J Public Health 2008, 18:184–188.
3. Smith AD, Bradley DJ, Smith V, Blaze M, Behrens RH, Chiodini PL, Whitty CJ:
Imported malaria and high risk groups: observational study using UK
surveillance data 1987–2006. BMJ 2008, 337:a120.
4. Swales CA, Chiodini PL, Bannister BA: New guidelines on malaria
prevention: a summary. J Infect 2007, 54:107–110.
5. Imported malaria cases by species and reason for travel, United Kingdom:
2007 to 2011. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/
HPAweb_C/1195733817568.
6. Phillips A, Bassett P, Zeki S, Newman S, Pasvol G: Risk factors for severe
disease in adults with falciparum malaria. Clin Infect Dis 2009, 48:871–878.
7. Ladhani S, Aibara RJ, Riordan FA, Shingadia D: Imported malaria in
children: a review of clinical studies. Lancet Infect Dis 2007, 7:349–357.
Pinsent et al. Malaria Journal 2014, 13:298 Page 8 of 8
http://www.malariajournal.com/content/13/1/2988. Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, Kendjo E,
Houze S, Le Bras J, Danis M, Durand R: Severe imported Plasmodium
falciparum malaria, France, 1996–2003. Emerg Infect Dis 2011, 17:807–813.
9. Behrens RH, Carroll B, Hellgren U, Visser LG, Siikamaki H, Vestergaard LS,
Calleri G, Janisch T, Myrvang B, Gascon J, Hatz C: The incidence of malaria
in travellers to South-East Asia: is local malaria transmission a useful risk
indicator? Malar J 2010, 9:266.
10. Zuckerman JN, Batty AJ, Jones ME: Effectiveness of malaria
chemoprophylaxis against Plasmodium falciparum infection in UK
travellers: retrospective observational data. Travel Med Infect Dis 2009,
7:329–336.
11. Gething PW, Patil AP, Hay SI: Quantifying aggregated uncertainty in
Plasmodium falciparum malaria prevalence and populations at risk via
efficient space-time geostatistical joint simulation. PLoS Comp Bio 2010,
6:e1000724.
12. Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, Noor AM, Kabaria CW,
Manh BH, Elyazar IR, Brooker S, Smith DL, Moyeed RA, Snow RW: A world
malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med 2009,
6:e1000048.
13. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W,
Bousema T, Drakeley CJ, Ferguson NM, Basanez MG, Ghani AC: Reducing
Plasmodium falciparum malaria transmission in Africa: a model-based
evaluation of intervention strategies. PLoS Med 2010, 7:e1000324.
14. Behrens RH, Carroll B, Smith V, Alexander N: Declining incidence of malaria
imported into the UK from West Africa. Malar J 2008, 7:235.
15. Millet JP, de Olalla PG, Gascon J, Prat JG, Trevino B, Pinazo MJ, Cabezos J,
Munoz J, Zarzuela F, Cayla JA: Imported malaria among African
immigrants: is there still a relationship between developed countries
and their ex-colonies? Malar J 2009, 8:111.
16. Unger HW, McCallum AD, Ukachukwu V, McGoldrick C, Perrow K, Latin G, Norrie
G, Morris S, Smith CC, Jones ME: Imported malaria in Scotland – an overview of
surveillance, reporting and trends. Travel Med Infect Dis 2011, 9:289–297.
17. Tatem AJ, Guerra CA, Kabaria CW, Noor AM, Hay SI: Human population,
urban settlement patterns and their impact on Plasmodium falciparum
malaria endemicity. Malar J 2008, 7:218.
18. Pavli A, Maltezou HC: Malaria and travellers visiting friends and relatives.
Travel Med Infect Dis 2010, 8:161–168.
19. Fulford M, Keystone JS: Health risks associated with visiting friends and
relatives in developing countries. Curr Infect Dis Rep 2005, 7:48–53.
20. Bisoffi Z: Malaria in travellers to Gambia. Euro Surveill 2008, 13(51).
21. Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS: Travel medicine
considerations for North American immigrants visiting friends and
relatives. JAMA 2004, 291:2856–2864.
22. Pistone T, Guibert P, Gay F, Malvy D, Ezzedine K, Receveur MC, Siriwardana M,
Larouze B, Bouchaud O: Malaria risk perception, knowledge and prophylaxis
practices among travellers of African ethnicity living in Paris and visiting
their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2007,
101:990–995.
23. Zuckerman JN: Imported malaria in the UK. BMJ 2008, 337:a135.
24. Neave PE, Jones CO, Behrens RH: A review of risk factors for imported
malaria in the European African diaspora. J Travel Med 2010, 17:346–350.
25. Van Herck K, Van Damme P, Castelli F, Zuckerman J, Nothdurft H, Dahlgren AL,
Gisler S, Steffen R, Gargalianos P, Lopez-Velez R, Overbosch D, Caumes E,
Walker E, Gisler S, Steffen R: Knowledge, attitudes and practices in
travel-related infectious diseases: the European airport survey. J Travel Med
2004, 11:3–8.
26. Stager K, Legros F, Krause G, Low N, Bradley D, Desai M, Graf S, D’Amato S,
Mizuno Y, Janzon R, Petersen E, Kester J, Seffen R, Schlagenhauf P: Imported
malaria in children in industrialized countries, 1992–2002. Emerg Infect
Dis 2009, 15:185–191.
27. Williams JP, Chitre M, Sharland M: Increasing Plasmodium falciparum
malaria in southwest London: a 25 year observational study. Arch Dis Child
2002, 86:428–430.
28. Garcia-Villarrubia M, Millet JP, de Olalla PG, Gascon J, Fumado V, iPrat JG,
Trevino B, Pinazo MJ, Cabezos J, Munoz J, Zarzuela F, Cayla JA:
Epidemiology of imported malaria among children and young adults in
Barcelona (1990–2008). Malar J 2011, 10:347.
29. Massad E, Behrens BC, Coutinho FA, Behrens RH: Cost risk benefit analysis
to support chemoprophylaxis policy for travellers to malaria endemic
countries. Malar J 2011, 10:130.
30. TravelPac 2007. http://www.ons.gov.uk/ons/rel/ott/travelpac/index.html.31. Bejon P, Williams TN, Liljander A, Noor AM, Wambua J, Ogada E, Olotu A,
Osier FH, Hay SI, Farnert A, Marsh K: Stable and unstable malaria hotspots
in longitudinal cohort studies in Kenya. PLoS Med 2010, 7:e1000304.
32. Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F, Otieno S,
Carneiro I, Cox J, Msuya E, Kleinschmidt I, Maxwell C, Greenwood B, Riley E,
Sauerwein R, Chandramohan D, Gosling R: Identification of hot spots of
malaria transmission for targeted malaria control. J Infect Dis 2010,
201:1764–1774.
33. Do CB, Batzoglou S: What is the expectation maximization algorithm?
Nat Biotechnol 2008, 26:897–899.
34. Leder K, Tong S, Weld L, Kain KC, Wilder-Smith A, von Sonnenburg F,
Black J, Brown GV, Torresi J: Illness in travelers visiting friends and relatives:
a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006,
43:1185–1193.
35. Fenner L, Weber R, Steffen R, Schlagenhauf P: Imported infectious disease
and purpose of travel, Switzerland. Emerg Infect Dis 2007, 13:217–222.
36. Zuckerman JN: Preventing malaria in UK travellers. BMJ 2004, 329:305–306.
37. Neave P, Behrens RH, Jones COH: “You’re losing your Ghanaianess”:
understanding malaria decision-making among Africans visiting friends
and relatives in the UK. Malar J 2014, 13:287.
38. Miura T, Kimura M, Koibuchi T, Endo T, Nakamura H, Odawara T, Wataya Y,
Nakamura T, Iwamoto A: Clinical characteristics of imported malaria in
Japan: analysis at a referral hospital. Am J Trop Med Hyg 2005, 73:599–603.
39. Weber R, Schlagenhauf P, Amsler L, Steffen R: Knowledge, attitudes and
practices of business travelers regarding malaria risk and prevention.
J Travel Med 2003, 10:219–224.
40. Wichmann O, Mühlberger N, Jelinek T: TropNetEurop surveillance data:
trends in imported malaria 2003. Euro Surveill 2004, 8:2492.
41. Romi R, Boccolini D, D’Amato S, Cenci C, Peragallo M, D’Ancona F, Pompa MG,
Majori G: Incidence of malaria and risk factors in Italian travelers to malaria
endemic countries. Travel Med Infect Dis 2010, 8:144–154.
42. Laver SM, Wetzels J, Behrens RH: Knowledge of malaria, risk perception,
and compliance with prophylaxis and personal and environmental
preventive measures in travelers exiting Zimbabwe from Harare and
Victoria Falls International airport. J Travel Med 2001, 8:298–303.
43. Ladhani S, Garbash M, Whitty CJ, Chiodini PL, Aibara RJ, Riordan FA,
Shingadia D: Prospective, national clinical and epidemiologic study on
imported childhood malaria in the United Kingdom and the Republic of
Ireland. Pediatr Infect Dis J 2010, 29:434–438.
44. Askling HH, Nilsson J, Tegnell A, Janzon R, Ekdahl K: Malaria risk in
travelers. Emerg Infect Dis 2005, 11:436–441.
45. Weber IB, Baker L, Mnyaluza J, Matjila MJ, Barnes K, Blumberg L: The burden
of imported malaria in Gauteng Province. S Afr Med J 2010, 100:300–303.
46. Pillai S, Siriez J-Y, Kendjo E, Houze S, Guerin P, Le Bras J: Childhood
imported malaria: could we have suppressed risk factors in some children?
Malar J 2012, 11(Suppl 1):53.
47. Boggild AK, Page AV, Keystone JS, Morris AM, Liles WC: Delay in diagnosis:
malaria in a returning traveller. CMAJ 2009, 180:1129–1131.
48. Dubos F, Dauriac A, El Mansouf L, Courouble C, Aurel M, Martinot A:
Imported malaria in children: incidence and risk factors for severity.
Diagn Microbiol Infect Dis 2010, 66:169–174.
49. Robert V, Macintyre K, Keating J, Trape JF, Duchemin JB, Warren M, Beir JC:
Malaria transmission in urban Sub-Saharan Africa. Am J Trop Med Hyg
2003, 68:169–176.
50. Bouchand O, Cot M, Kony S, Durand R, Schiemnann R, Ralaimazava P,
Couland JP, Le Bras J, Derlon P: Do African immigrants living in France
have long-tern malarial immunity? Am J Trop Med Hyg 2005, 72:21–25.
51. Moore DAJ, Grant AD, Armstrong M, Stümpfle R, Behrens RH: Risk factors
for malaria in UK travellers. Trans R Soc Trop Med Hyg 2004, 98:55–63.
doi:10.1186/1475-2875-13-298
Cite this article as: Pinsent et al.: Risk factors for UK Plasmodium
falciparum cases. Malaria Journal 2014 13:298.
